Roche unveils major upgrade to cobas 6800/8800 systems, boosting lab efficiency
The update promises to revolutionize laboratory workflows by optimizing resources
The update promises to revolutionize laboratory workflows by optimizing resources
If cleared by regulators, CagriSema would become the first treatment to combine a GLP-1 receptor agonist and a long-acting amylin analogue in a single injection
India plays a critical role in Bristol Myers Squibb’s global strategy
Roche says its new assay “resolves this challenge by delivering accurate and specific results
Tirzepatide is the first and only dual agonist glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Roche says the move marks a step forward in its digital transformation strategy
Subscribe To Our Newsletter & Stay Updated